What is required for every new antibody introduced for diagnostic use?

• A. It must be technically optimized to maximize signal-to-noise and must be validated and verified.
• B. It must be produced by hybridoma technology.
• C. It must be the highest affinity regardless of specificity.
• D. It must be compatible with all detection systems.

Answer: (A)

In diagnostic immunohistochemistry, a new antibody must be fine-tuned for the assay and then shown to perform reliably. Technically optimizing it to maximize signal-to-noise ensures that true staining stands out against background, which is essential for accurate interpretation. After optimization, the antibody must be validated and verified: validation demonstrates that it meets predefined clinical use requirements and performance characteristics for the intended application, while verification shows that the lab can reproduce those results with its own processes, specimens, and equipment.

The other ideas don’t fit because the production method isn’t the universal requirement for diagnostic use, and antibodies can be produced in multiple ways. Pursuing the highest affinity without regard to specificity can increase off-target binding and background, undermining diagnostic accuracy. Finally, being compatible with all detection systems isn’t practical; an antibody is typically validated for the specific system and protocol it will be used with.